REFERENCES
- Barnes PJ. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 2010; 120: 76–85.
- Belvisi MG. Regulation of inflammatory cell function by corticosteroids. Proc Am Thorac Sac 2004; 1:207–214.
- Buttgereit F, Burmester GR, Lipworth BJ. Optimised glucocorticoid therapy: the sharpening of an old spear. Lancet 2005; 365: 801–803.
- Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome. Lancet 2006; 367: 1605–1617.
- Nieman LK, Ilias I. Evaluation and treatment of Cushing's syndrome. Am J Med 2005; 118:1340–1346.
- Bertagna X, Guignat L, Groussin L, Bertherat J. Cushing's disease. Best Pract Res Clin Endocrinol Metab 2009; 23: 607–623.
- Biller BM, Grossman AB, Stewart PM et al. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2008; 93: 2454–2462.
- Fanta CH. Asthma. N Engl J Med 2009; 360: 1002–1014.
- Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006; 368: 780–793.